BioStem Technologies (BioStem Technologies) EBIT per Share : $-0.35 (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies EBIT per Share?

BioStem Technologies's EBIT per Share for the three months ended in Sep. 2023 was $0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.35.

During the past 3 years, the average EBIT per Share Growth Rate was 12.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 26.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 25.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BioStem Technologies's EBIT per Share or its related term are showing as below:

BSEM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -68.1 Med: 30.8 Max: 80.3
Current: 12.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BioStem Technologies was 80.30% per year. The lowest was -68.10% per year. And the median was 30.80% per year.

BSEM's 3-Year EBIT Growth Rate is ranked better than
61.99% of 1305 companies
in the Biotechnology industry
Industry Median: 3.5 vs BSEM: 12.50

BioStem Technologies's EBIT for the three months ended in Sep. 2023 was $0.53 Mil.

BioStem Technologies EBIT per Share Historical Data

The historical data trend for BioStem Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies EBIT per Share Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-0.92

-0.61

-0.20

-0.08

-0.58

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
EBIT per Share	Get a 7-Day Free Trial															-0.28	-0.07	-0.26	-0.13	0.04

BioStem Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BioStem Technologies's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.646	/	11.405
=	-0.58

BioStem Technologies's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.529	/	13.493
=	0.04

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35

BioStem Technologies (OTCPK:BSEM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BioStem Technologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.